29 related articles for article (PubMed ID: 1588802)
1. Drug Sensitivity Assays of Human Cancer Organoid Cultures.
Francies HE; Barthorpe A; McLaren-Douglas A; Barendt WJ; Garnett MJ
Methods Mol Biol; 2019; 1576():339-351. PubMed ID: 27628132
[TBL] [Abstract][Full Text] [Related]
2.
Seliger B; Al-Samadi A; Yang B; Salo T; Wickenhauser C
Front Med (Lausanne); 2022; 9():971726. PubMed ID: 36160162
[TBL] [Abstract][Full Text] [Related]
3. Ex Vivo Culture Models to Indicate Therapy Response in Head and Neck Squamous Cell Carcinoma.
Demers I; Donkers J; Kremer B; Speel EJ
Cells; 2020 Nov; 9(11):. PubMed ID: 33238461
[TBL] [Abstract][Full Text] [Related]
4. Feasibility of Primary Tumor Culture Models and Preclinical Prediction Assays for Head and Neck Cancer: A Narrative Review.
Dohmen AJ; Swartz JE; Van Den Brekel MW; Willems SM; Spijker R; Neefjes J; Zuur CL
Cancers (Basel); 2015 Aug; 7(3):1716-42. PubMed ID: 26343729
[TBL] [Abstract][Full Text] [Related]
5. Cell, tissue and organ culture as in vitro models to study the biology of squamous cell carcinomas of the head and neck.
Sacks PG
Cancer Metastasis Rev; 1996 Mar; 15(1):27-51. PubMed ID: 8842478
[TBL] [Abstract][Full Text] [Related]
6. Organoid development in cancer genome discovery.
Gao D; Chen Y
Curr Opin Genet Dev; 2015 Feb; 30():42-8. PubMed ID: 25796043
[TBL] [Abstract][Full Text] [Related]
7. An organoid culture assay (OCA) for determining the drug sensitivity of human tumors.
Köpf-Maier P; Kolon B
Int J Cancer; 1992 Apr; 51(1):99-107. PubMed ID: 1563848
[TBL] [Abstract][Full Text] [Related]
8. Organoid reorganization of human tumors under in vitro conditions.
Köpf-Maier P; Zimmermann B
Cell Tissue Res; 1991 Jun; 264(3):563-76. PubMed ID: 1868523
[TBL] [Abstract][Full Text] [Related]
9. Head and neck cancer organoids established by modification of the CTOS method can be used to predict in vivo drug sensitivity.
Tanaka N; Osman AA; Takahashi Y; Lindemann A; Patel AA; Zhao M; Takahashi H; Myers JN
Oral Oncol; 2018 Dec; 87():49-57. PubMed ID: 30527243
[TBL] [Abstract][Full Text] [Related]
10. Appendiceal Cancer Patient-Specific Tumor Organoid Model for Predicting Chemotherapy Efficacy Prior to Initiation of Treatment: A Feasibility Study.
Votanopoulos KI; Mazzocchi A; Sivakumar H; Forsythe S; Aleman J; Levine EA; Skardal A
Ann Surg Oncol; 2019 Jan; 26(1):139-147. PubMed ID: 30414038
[TBL] [Abstract][Full Text] [Related]
11. Efficient use of patient-derived organoids as a preclinical model for gynecologic tumors.
Maru Y; Tanaka N; Itami M; Hippo Y
Gynecol Oncol; 2019 Jul; 154(1):189-198. PubMed ID: 31101504
[TBL] [Abstract][Full Text] [Related]
12. A new approach for realizing the "antioncogram".
Köpf-Maier P
Life Sci; 1992; 50(22):1711-8. PubMed ID: 1588802
[TBL] [Abstract][Full Text] [Related]
13. Functional Optical Imaging of Primary Human Tumor Organoids: Development of a Personalized Drug Screen.
Walsh AJ; Cook RS; Skala MC
J Nucl Med; 2017 Sep; 58(9):1367-1372. PubMed ID: 28588148
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
